|
Perioperative acute kidney injuryKeywords: Acute kidney injury, Biomarkers, Perioperative, Pharmacological interventions, Risk stratification Abstract: Acute kidney injury (AKI) occurs in 1% to 5% of all hospital admissions, and in the perioperative period has serious implications, being consistently associated with (unacceptably) high mortality, morbidity and a more complicated hospital course with associated cost implications. This is particularly the case when renal replacement therapy (RRT) is required [1-22]. It is widely recognized that AKI requiring dialysis is an independent risk factor for death [1-3]; more recently, however, even minimal increases in serum creatinine have been associated with an increase in both short and long-term mortality, regardless of whether partial or full recovery of renal function has occurred at the time of discharge [4-11]. This risk of death is independent from other postoperative complications and co-morbidities [7-9]. AKI is related to the subsequent development and progression of chronic kidney disease (CKD) and the need for future dialysis, most notably in those with a degree of pre-existing renal impairment [11-15], but also in those who have apparent recovery following an episode of AKI [7]. Despite an increase in our knowledge of AKI and advances in other relevant areas over the last two decades (including intensive care, delivery of dialysis and surgical techniques), there have been no significant changes in these outcomes [12,15-17]. As such, identification of risk factors, close monitoring of renal function and early adoption of both preventive measures and treatments remain important considerations for those taking care of perioperative patients who are likely to develop AKI.Surgery remains a leading cause of AKI in hospitalized patients (the incidence ranges from 18% to 47% depending on the definition used) [17,18]. This has been best researched in the cardiac surgery setting where it has been shown that up to 15% of patients exposed to cardiopulmonary bypass (CPB) will develop AKI, with 2% requiring RRT [23]. Depending on the criteria used to define AKI and the po
|